Kyle Moran, Chief Financial Officer at Wave Life Sciences Ltd. (WVE), sold 17,146 shares at $9.00 ($154K) on 2024-09-25, disclosed to the SEC on 2024-09-27.
Scheduled sale ($154k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| WVE | SELL | 2024-04-05 | $193K | — | Filing → |
| WVE | SELL | 2023-08-23 | $352K | — | Filing → |
| WVE | SELL | 2023-02-17 | $39K | — | Filing → |